Treatment of schizophrenia and bipolar disorder (ChAD) - a review of the literature
Introduction and aims of the study: The aim of this study is to present recent reports on the treatment and therapy of schizophrenia and bipolar disorder (ChAD). The current treatment of patients affected by these diseases is difficult and unsatisfactory, therefore it is necessary to find new therap...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kazimierz Wielki University
2021-09-01
|
| Series: | Journal of Education, Health and Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/JEHS/article/view/35398 |
| _version_ | 1818249938087182336 |
|---|---|
| author | Jakub Klas Natalia Kluz Mikołaj Makaryczew Klaudia Piwowar |
| author_facet | Jakub Klas Natalia Kluz Mikołaj Makaryczew Klaudia Piwowar |
| author_sort | Jakub Klas |
| collection | DOAJ |
| description | Introduction and aims of the study: The aim of this study is to present recent reports on the treatment and therapy of schizophrenia and bipolar disorder (ChAD). The current treatment of patients affected by these diseases is difficult and unsatisfactory, therefore it is necessary to find new therapeutic options that will improve the effectiveness of treatment
For the purpose of this study, scientific papers were reviewed using the Google Scholar search engine covering studies from 2016 to 2021. A dozen papers covering the scope of the publication were selected.
Results: In the treatment of schizophrenia, the use of cannabinoids is of greatest interest due to the action of the preparations on the endocannabinoid system. In the treatment of ChaD, promising reports have been published on the therapy with aripiprazole and the need to improve its use in the treatment of both akathisia and agitation. Furthermore, from the fact that abnormalities of calcium signalling are considered a possible pathophysiological process in ChAD, it has been suggested that calcium channel L antagonists may be potential therapeutic agents in bipolar affective disorder. One study also demonstrated the potential use of vortioxetine in the treatment of patients with a depressive episode.
Conclusions: The results of recent studies on the treatment of schizophrenia and ChAD cited in this paper offer the prospect of creating treatment regimens that are more effective and targeted in the aforementioned diseases. However, further randomised trials are needed to confirm the effective use of the cited drugs in the treatment of these diseases.
|
| first_indexed | 2024-12-12T15:44:26Z |
| format | Article |
| id | doaj.art-ee50195d27c24c36a50dae5b6ba514ce |
| institution | Directory Open Access Journal |
| issn | 2391-8306 |
| language | English |
| last_indexed | 2024-12-12T15:44:26Z |
| publishDate | 2021-09-01 |
| publisher | Kazimierz Wielki University |
| record_format | Article |
| series | Journal of Education, Health and Sport |
| spelling | doaj.art-ee50195d27c24c36a50dae5b6ba514ce2022-12-22T00:19:50ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062021-09-0111910.12775/JEHS.2021.11.09.061Treatment of schizophrenia and bipolar disorder (ChAD) - a review of the literatureJakub Klas0Natalia Kluz1Mikołaj Makaryczew2Klaudia Piwowar3Medical University of LublinMedical University of LublinMedical University of LublinMedical University of LublinIntroduction and aims of the study: The aim of this study is to present recent reports on the treatment and therapy of schizophrenia and bipolar disorder (ChAD). The current treatment of patients affected by these diseases is difficult and unsatisfactory, therefore it is necessary to find new therapeutic options that will improve the effectiveness of treatment For the purpose of this study, scientific papers were reviewed using the Google Scholar search engine covering studies from 2016 to 2021. A dozen papers covering the scope of the publication were selected. Results: In the treatment of schizophrenia, the use of cannabinoids is of greatest interest due to the action of the preparations on the endocannabinoid system. In the treatment of ChaD, promising reports have been published on the therapy with aripiprazole and the need to improve its use in the treatment of both akathisia and agitation. Furthermore, from the fact that abnormalities of calcium signalling are considered a possible pathophysiological process in ChAD, it has been suggested that calcium channel L antagonists may be potential therapeutic agents in bipolar affective disorder. One study also demonstrated the potential use of vortioxetine in the treatment of patients with a depressive episode. Conclusions: The results of recent studies on the treatment of schizophrenia and ChAD cited in this paper offer the prospect of creating treatment regimens that are more effective and targeted in the aforementioned diseases. However, further randomised trials are needed to confirm the effective use of the cited drugs in the treatment of these diseases. https://apcz.umk.pl/JEHS/article/view/35398schizophreniaChADbipolar disorder |
| spellingShingle | Jakub Klas Natalia Kluz Mikołaj Makaryczew Klaudia Piwowar Treatment of schizophrenia and bipolar disorder (ChAD) - a review of the literature Journal of Education, Health and Sport schizophrenia ChAD bipolar disorder |
| title | Treatment of schizophrenia and bipolar disorder (ChAD) - a review of the literature |
| title_full | Treatment of schizophrenia and bipolar disorder (ChAD) - a review of the literature |
| title_fullStr | Treatment of schizophrenia and bipolar disorder (ChAD) - a review of the literature |
| title_full_unstemmed | Treatment of schizophrenia and bipolar disorder (ChAD) - a review of the literature |
| title_short | Treatment of schizophrenia and bipolar disorder (ChAD) - a review of the literature |
| title_sort | treatment of schizophrenia and bipolar disorder chad a review of the literature |
| topic | schizophrenia ChAD bipolar disorder |
| url | https://apcz.umk.pl/JEHS/article/view/35398 |
| work_keys_str_mv | AT jakubklas treatmentofschizophreniaandbipolardisorderchadareviewoftheliterature AT nataliakluz treatmentofschizophreniaandbipolardisorderchadareviewoftheliterature AT mikołajmakaryczew treatmentofschizophreniaandbipolardisorderchadareviewoftheliterature AT klaudiapiwowar treatmentofschizophreniaandbipolardisorderchadareviewoftheliterature |